Concurrent Transcranial Direct Current Stimulation and Gait Training in Parkinson's Disease

NCT ID: NCT04041661

Last Updated: 2019-08-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-08-01

Study Completion Date

2020-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the effect of concurrent transcranial direct current stimulation and gait training on gait performance when doing the cognitive dual-task in people with Parkinson's Disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active tDCS plus gait training group

Participants in Active tDCS plus gait training group will execute Active tDCS on left dorsolateral prefrontal cortex which combined with treadmill, 12 times per week, least 4 weeks.

Group Type EXPERIMENTAL

Active tDCS plus gait training

Intervention Type OTHER

Participants in experimental group will accept Active tDCS which combined with treadmill

Sham tDCS plus gait training group

Participants in Sham tDCS plus gait training group will executeSham tDCS on left dorsolateral prefrontal cortex which combined with treadmill, 12 times per week, least 4 weeks.

Group Type SHAM_COMPARATOR

Sham tDCS plus gait training

Intervention Type OTHER

Participants in control group will accept Sham tDCS which combined with treadmill

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Active tDCS plus gait training

Participants in experimental group will accept Active tDCS which combined with treadmill

Intervention Type OTHER

Sham tDCS plus gait training

Participants in control group will accept Sham tDCS which combined with treadmill

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with idiopathic PD
* Hoehn and Yahr stages I-III
* Mini Mental Status Examination (MMSE) score ≧ 24
* Could walk 10m independently with or without gait aid

Exclusion Criteria

* Concurrent medication likely to affect mental performance
* tDCS contraindication
* Significant neurological, vestibular, visual disorders or psychiatric illness
* Musculoskeletal or cardiopulmonary disease
* Sensory system pathology
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Yang Ming Chiao Tung University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yea-Ru Yang

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yearu Yang, Ph.D

Role: CONTACT

+88628267279

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

19MMHIS113e

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.